Hypothalamic Hamartomas: Correlation of MR Imaging and Spectroscopic Findings with Tumor Glial Content

References

1. ↵
   Judge D, Kulin H, Page R, et al. Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. N Engl J Med 1977;296:7–10

   PubMedWeb of Science
2. Inoue H, Kanazawa H, Kohga H, et al. Hypothalamic hamartoma: anatomic, immunohistochemical, and ultrastructural features. Brain Tumor Pathol 1995;12:45–51
3. ↵
   Diebler C, Ponsot G. Hamartomas of the tuber cinereum. Neuroradiology 1983;25:93–101

   CrossRefPubMedWeb of Science
4. ↵
   Veldueza J, Cristante L, Dammann O, et al. Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery 1994;34:949–58

   PubMedWeb of Science
5. ↵
   Grossman R, Yousem D. Neuroradiology: The Requisites. 2nd ed. Philadelphia, Pa: Mosby;2003 :548–50
6. ↵
   Osborn Anne. Diagnostic Imaging:. Brain. Vol. II. Salt Lake City, Utah: Amirsys;2004 :2:12
7. ↵
   Martin D, Seeger U, Ranke M, et al. MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism. AJNR Am J Neuroradiol 2003;24:1177–80

   Abstract/FREE Full Text
8. ↵
   Barkovich A. Intracranial, Orbital and Neck Tumors of Childhood: Pediatric Neuroimaging. Philadelphia, Pa: Lippincott Williams & Wilkins;2000 :443–580
9. ↵
   Freeman JL, Coleman LT, Wellard RM, et al. MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases. AJNR Am J Neuroradiol 2004;25:450–62

   Abstract/FREE Full Text
10. ↵
    Richter RB. True hamartoma of the hypothalamus associated with pubertas praecox. J Neuropathol Exp Neurol 1951;10:368–83

    CrossRefPubMedWeb of Science
11. ↵
    Kahane P, Tassi L, Hoffmann D. Cries dacrystiques et hamartome hypothlamique: a propos d’une observation video-EEG. Epilepsies 1994;6:259–79
12. ↵
    Northfield D, Russell D. Pubertas praecox due to hypothalamic hamartoma: report of two cases surviving surgical removal of the tumour. J Neurol Neurosurg Psychiatry 1967;30:166–73

    FREE Full Text
13. ↵
    Georgakoulias N, Vize C, Jenkins A, et al. Hypothalamic hamartomas causing gelastic epilepsy: two cases and a review of the literature. Seizure 1998;7:167–71

    PubMedWeb of Science
14. ↵
    Wakai S, Nikaido K, Nihira H, et al. Gelastic seizure with hypothalamic hamartoma: proton magnetic resonance spectrometry and ictal electroencephalographic findings in a 4-year-old girl. J Child Neurol 2002;17:44–46

    Abstract/FREE Full Text
15. ↵
    Tasch E, Cendes F, Li L, et al. Hypothalamic hamartomas and gelastic epilepsy: a spectroscopic study. Neurology 1998;51:1046–50

    Abstract/FREE Full Text
16. ↵
    Akai T, Okamoto K, Iizuka H, et al. Treatments of hamartoma with neuroendoscopic surgery and stereotactic radiosurgery: a case report. Minim Invas Neurosurg 2002;45:235–39

    CrossRefPubMed
17. ↵
    Krieger MD, Panigrahy A, McComb JG, et al. Differentiation of choroid plexus tumors by advanced magnetic resonance spectroscopy. Neurosurg Focus 2005;15:18
18. ↵
    Kawaguchi T, Kumabe T, Shimizu H, et al. 201Tl-SPECT and 1H-MRS study of benign lateral ventricle tumors: differential diagnosis of subependymoma. Neurosurg Rev 2005;28:96–103

    CrossRefPubMed
19. ↵
    Urenjak J, Williams S, Gadian D, et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–89

    Abstract
20. ↵
    Ross B. Biochemical considerations in 1H spectroscopy: glutamate and glutamine—myo-inositol and related metabolites. NMR Biomed 1991;4:59–63

    PubMedWeb of Science
21. ↵
    Miller BL. A review of chemical issues in ¹H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47–52

    PubMedWeb of Science
22. ↵
    Kim JP, Lentz MR, Westmoreland SV, et al. Relationships between astrogliosis and ¹H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol 2005;26:752–59

    Abstract/FREE Full Text
23. ↵
    Strange K, Emma F, Paredes A, et al. Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia 1994;12:35–43

    CrossRefPubMedWeb of Science
24. ↵
    Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645–49

    Abstract/FREE Full Text
25. ↵
    Saraf-Lavi E, Bowen BC, Pattany PM, et al. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels. AJNR Am J Neuroradiol 2003;24:946–51

    Abstract/FREE Full Text
26. ↵
    Fernando KTM, McLean MA, Chard DT, et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004;127:1361–69

    Abstract/FREE Full Text
27. ↵
    Rumpel H, Lim WE, Chang HM, et al. Is myo-inositol a measure of glial swelling after stroke? A magnetic resonance study. J Magn Reson Imaging 2003;17:11–19

    CrossRefPubMed
28. ↵
    Robertson NJ, Lewis RH, Cowan FM, et al. Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatr Res 2001;50:692–700

    PubMedWeb of Science
29. ↵
    Jones RS, Waldman AD. ¹H-MRS evaluation of metabolism in Alzheimer’s disease and vascular dementia. Neurol Res 2004;26:488–95

    CrossRefPubMedWeb of Science
30. ↵
    Londono A, Castillo M, Armano D, et al. Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels. AJNR Am J Neuroradiol 2003;24:942–45

    Abstract/FREE Full Text